Boston Scientific announced today that its Farapulse pulsed-field ablation (PFA) system has received expanded CE mark ...

"It's not mysterious. It's complex." ...

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in ad ...

Advanced imaging and neurological-focused evaluation are gaining attention among patients with migraines, vertigo, and ...

"If they'd have picked up on the infection and I'd been given antibiotics it could have been a completely different story and ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

Approval based on unprecedented Phase 3 data demonstrating statistically significant improvements in progression-free survival and overall survival versus standard of care regimens83.3% of ...

Allied Market Research published a report, titled, "Cardiac Ablation Market by Product (Radiofrequency (RF) Ablators, ...

I suffered with my mystery illness for decades before gaining a diagnosis. Could retraining my brain be the answer?

Katie Robertson, who gained a following on social media as The Wheeled Piper, has navigated several different chronic ...

Doctors are divided over treatment for a rare disorder, but some living with it say the official advice is misleading.

A female in her early 30s with a previous history of postpartum granulomatous hypophysitis presented with palpitations and a syncopal episode. She was haemodynamically unstable on arrival with a heart ...